Challenges of persons with multiple sclerosis on ocrelizumab treatment during COVID‐19 pandemic
Abstract
Coronavirus disease of the 2019 pandemic caused much fear among people with chronic diseases and those on immunosuppressant treatment because of spreading knowledge that the infection has a fatal course in these populations. People with Multiple Sclerosis on ocrelizumab treatment share this fear too. We aimed to investigate treatment and lifestyle changes of people with multiple sclerosis on ocrelizumab treatment during the lockdown.We surveyed...
Paper Details
Title
Challenges of persons with multiple sclerosis on ocrelizumab treatment during COVID‐19 pandemic
Published Date
Oct 28, 2021
Volume
10
Issue
1
Pages
3 - 8
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History